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httpcense.Abstract Background: Obstructive sleep apnea syndrome (OSAS) is a common disease, affecting
about 2–4% of the adult population. Some of the symptoms of OSAS resemble symptoms associ-
ated with anxiety and depressive conditions in untreated OSAS, rates of depression are elevated
compared with general populations, studies of (CPAP) treatment in OSAS have shown an improve-
ment in symptoms of depression.
Aim: To assess depression in patients with obstructive sleep apnea syndrome (OSAS), and the
effect of CPAP on it.
Patients and methods: This study comprised 30 cases who underwent full history taking, general
and local examinations, assessment of daytime sleepiness by Epworth scale, overnight polysomnog-
raphy using (Embla S 4000, Iceland) and assessment of depression before and 2 month after treat-
ment with CPAP by The Hamilton Depression Rating Scale (HDRS), The Structured Clinical
Interview for DSM-IV (SCID) and BECK scale for depression.
Results: The mean age of patients was 55 years. Sixteen patients had HDRS scores above the cut-
off point of the scale of ten (indicating some sort of depression). After that patients were subjected to
SCID. Ten patients (33.3%) fulﬁlled the clinical diagnosis of a major depressive disorder according
to DSM-IV and after CPAP treatment for two months resulted in signiﬁcant improvements of
depressive symptoms in both BDI and HRSD scores. The BDI score decreased from 18.6 ± 9.2
to 9.4 ± 10.1, while the HRSD score decreased from 14.1 ± 8.5 to 7.9 ± 7.2 (both p< 0.01).
Conclusion: OSA is associated with depression which improved after CPAP treatment.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V.Open access under CC BY-NC-ND license.1006831676.
com (S.S. Eldahdouh).
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Obstructive sleep apnea syndrome (OSAS) is a common dis-
ease, affecting about 2–4% of the adult population [1–3].
Patients with OSAS have increased morbidity compared
with the general population [4–7]. Tiredness, daytime sleepi-
ness, headache, and obesity are common symptoms of OSAS,
which often lead to inactivity and cardiovascular or other
organ manifestations.is. Production and hosting by Elsevier B.V.
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Table 1 Demographic data and classiﬁcation of OSA.
Parameters Number %
SEX:
Female 12 40.0
Male 18 60.0
AHI:
Mild OSA (5–15/h) 5 16.7
Moderate (15–30/h) 15 50.0
Sever (>30/h) 10 33.3
Parameters Mean SD Range
Age in years 55 17.6 (18–72)
390 S.S. Eldahdouh et al.Some of the symptoms of OSAS resemble symptoms asso-
ciated with anxiety and depressive conditions. However, clini-
cians may have problems in differentiating psychiatric disease
from symptoms related to organic disease [3].
Early studies found an increased likelihood of depression in
sleepy patients [8,9]. Later, several studies have investigated
the association of OSAS with depression and anxiety; however,
the relationship is still poorly understood.
In untreated OSAS, rates of depression are elevated com-
pared with general populations [9,10], although not necessarily
at a pathological level [9]. In contrast, some other studies have
been unable to conﬁrm this association between OSAS and
anxiety or depression [11].
Some studies of continuous positive airway pressure
(CPAP) treatment in OSAS have shown an improvement in
symptoms of depression [8,12,13].
Aim of the work
To assess depression in patients with obstructive sleep apnea
syndrome (OSAS), and the effect of CPAP on it.
Patients and methods
This study was done on 30 patients who attended the chest
department, minouﬁa university hospitals, and a written con-
sent was obtained from each patient participating in the study.
All the patients underwent the following;
1- Full history taking.
2- Physical examination (general and local).
3- Assessment of daytime sleepiness.
The Epworth Sleepiness Scale (ESS) was used for assessing
daytime sleepiness .This is a commonly used self-administered
scalewith eight items about how easily the respondentwould fall
asleep in different situations. The items are scored on a 0–3 scale,
which are added to give an overall score of 0–24. Higher scores
indicate more sleepiness. ESS score 2–10 is considered ‘normal’
and more than 10 indicative of pathological sleepiness [14].
4-Complete overnight polysomnography using (Embla S
4000, Iceland) in the sleep laboratory, Minouﬁa University
Hospital overnight (8 h sleep) using EMBLA S 4000 system,
which records the following: Sleep stages by EEG, EOG and
EMG, Oxygen saturation, Snoring, Flattening index, Body po-
sition, Nasal ventilation, Respiratory effort and Apnea Hyp-
opnoea index.
5-Assessment of depression before and 2 month after treat-
ment with CPAP by:
1-The Hamilton Depression Rating Scale (HDRS) is an
inventory employed to detect and identify the intensity or
severity of the signs and symptoms of depression; 17 questions
are divided into two categories. The ﬁrst category consists of
nine questions scored on a ﬁve-point scale; the second category
consists of eight questions rated on a three-point scale. A total
score is computed reﬂecting the degree of symptom severity. A
score >7 indicates impairment [15].
HAM-D Scoring Instructions (Cut-Off Scores)
0–7 Normal.
8–13 Mild depression.14–18 Moderate depression.
>18 Severe depression.
NB: A total HAM-D score of 7 or less after treatment is for
most raters a typical indicator of remission. A decrease of 50%
or more from baseline during the course of the treatment is
considered an indicator of clinical response, or in other words,
a clinically signiﬁcant change.
2-Beck Depression Inventory (BDI), is a self-reported 21-
item Beck Depression Inventory (BDI). We used a cut off of
>9 to classify BDI measures as high, a threshold lower than
the typical 14 but a more sensitive level [16].
3-The Structured Clinical Interview for DSM-IV (SCID) is a
semistructured interview used to establish the major Axis I
diagnoses in DSM-IV. It is administered by a clinician and in-
cludes an introductory overview followed by nine modules, se-
ven of which represent the major Axis I diagnostic classes.
Only the section on mood disorders was used and it is more
accurate than scales [17].
The following patients were excluded:
1- Patients with previous psychiatric disorders.
2- Patients were on antidepressant treatment.
3- Patients with chronic diseases (respiratory, renal, hepa-
tic, cardiac, and neurological disorders).
Data were analyzed using SPSS (v 15.0). Means with stan-
dard deviations or percentages were used to describe the sample.
Group differences were assessed with unpaired t-tests and the
changes after treatment were assessed with paired t-tests. A P
value <0.05 was considered to indicate statistical signiﬁcance.
Results
This study included 30 patients, 18 males and 12 females, aged
18–72 years with mean 55 years with SD 17.6, 5 patients had
mild OSA, 15 patients had moderate OSA and 10 patients
had severe OSA (Table 1). Sixteen patients had HDRS scores
above the cut-off point of the scale of ten (indicating some sort
of depression), 10 patients (33.33%) had mild depressive symp-
toms, while 4 patients had moderate symptoms (13.33%), and
2 patients (6.67%) had severe symptoms (Table 2).
It is important to note that the levels of depressive symp-
toms obtained from the Hamilton scale are not necessarily al-
ways equate with a formal categorical diagnosis of major
depressive disorder. Females had higher scores than males.
Table 2 Assessment of patients by HDRS and SCID (ﬁrst examination).
Males (N= 18) Females (N= 12) Total (N= 30)
HDRS
Normal 9 (50%) 5 (41.66%) 14 (46.67%) Chi-square = 1.8
P= 0.6Mild 6 (33.33%) 4 (33.33%) 10 (33.33%)
Moderate 2 (11.11%) 2 (16.66%) 4 (13.33%)
Severe 1 (5.55%) 1 (8.33%) 2 (6.67%)
SCID
No disorder 13 (72.22%) 7 (58.33%) 20 (66.66%) Chi-square = 0.8
P= 0.7Mild depression 3 (16.67%) 3 (25%) 6 (20%)
Mod depression 2 (11.11%) 2 (16.66%) 4 (13.33%)
N.B:Mild depression = major depressive episode, mild; mod depression = major depressive episode, moderate; HDRS: Hamilton Depression
Rating Scale; SCID: Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition.
Table 3 Comparison between depressed patients on HDRS before and after CPAP treatment.
Number HDRS at baseline Mean ± SD HDRS at follow-up Mean ± SD Diﬀerences
T P
Normal 14 4.7 ± 2.9 1.6 ± 1.2 4.8 0.00
Mild 10 10.7 ± 0.7 6.9 ± 1.8 11.2 0.00
Moderate 4 14.9 ± 0.9 10.8 ± 0.8 5.2 0.03
Severe 2 34.8 ± 3.7 27.1 ± 3.1 2.9 0.045
Total 16 14.1 ± 8. 7.9 ± 7.2 8.1 0.001
There was a statistically signiﬁcant decrease in the HDRS in all groups (mild, moderate and severe depression) when patients with OSA used the
CPAP for 2 months.
Table 4 Comparison between depressed patients on SCID
before and after CPAP treatment.
SCID before CPAP SCID after CPAP
SCID N (%) N (%)
No disorder 20 (66.66%) 25 (83.33%)
Mild depression 6 (20%) 4 (13.33%)
Mod depression 4 (13.33%) 1 (13.33%)
Before CPAP
After CPAP0
5
10
15
20
BDI
HRDS
Before CPAP
Aer CPAP
Figure 1 Change in total scores of BDI and HRSD and after
2 month of CPAP treatment.
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(33.3%) fulﬁlled the clinical diagnosis of a major depressive
disorder according to DSM-IV, six patients with mild depres-
sive episodes and four patients with moderate depressive epi-
sodes. There was no statistically signiﬁcant difference
between males and females on either parameter (HDRS and
SCID).
Five of the ten patients diagnosed with a depressive episode
by the SCID before to using the CPAP, no longer met the diag-
nostic criteria needed for the diagnosis of a depressive episode
after the use of CPAP.
While only 4 patients met the diagnosis of a mild depressive
episode (3 patients with moderate depression changed to mild
depression after CPAP and one patient from 6 patients with
mild depression before CPAP remains the same).
Only one patient from 4 patients with moderate
before CPAP remains with moderate depression (Tables 3
and 4).Fig. 1 shows a comparison of the total scores of BDI and
HRSD between pre-CPAP and post-CPAP treatment in
MDD patients with OSA (n= 30).
CPAP treatment for two months resulted in signiﬁcant
improvements of depressive symptoms in both BDI and
HRSD scores. The BDI score decreased from 18.6 ± 9.2 to
9.4 ± 10.1, while the HRSD score decreased from 14.1 ± 8.5
to 7.9 ± 7.2 (both P< 0.01) (Tables 3,4 and Fig. 1).
Discussion
In this study, it was aimed to determine the rate of depressive
symptoms associated with OSA. More than half of the studied
samples (53.3%) had depressive symptoms as measured by
HDRS; six of these patients (20%) had clinically signiﬁcant
moderate to severe symptoms. This high prevalence is in line
392 S.S. Eldahdouh et al.with ﬁndings reported in some studies in which OSA was
highly associated with depression [11].
Females showed a higher rate of depression although this
difference was not statistically signiﬁcant; females had statisti-
cally higher scores than males on the HDRS, and this ﬁnding
has been reported in previous studies [17,18].
When using the SCID to establish a DSM-IV diagnosis, the
total number of individuals with a clinical diagnosis of depres-
sive disorder was ten (33.33%), and there was no statistically
signiﬁcant difference between females and males in the rate
of occurrence of depressive disorders using this method.
We can conclude that the prevalence of depression in the
same sample varied according to the tool used, with a high
prevalence when measured with the HDRS, a tool used mainly
to measure the severity of depressive symptoms rather than to
generate a diagnosis. This ﬁnding can explain some of the dif-
ferences in the rate of depression in individuals with OSA
found across different studies [19,20].
At follow-up, marked improvement of depression was
found after the use of CPAP, as reﬂected by statistically signif-
icant improvement on the HDRS. In addition, only ﬁve pa-
tients of those diagnosed with the SCID as having a
depressive disorder still met the DSM-IV diagnostic criteria
for a depressive episode after CPAP treatment. These patients
might require speciﬁc antidepressant treatment whereas the
other ﬁve patients would not require additional treatment
apart from CPAP. Most studies showed improvement of
depressive symptoms with the use of the CPAP [21,22], and
this ﬁnding is replicated in the current study, but some studies
[23,24] found no improvement in depression after CPAP use.
In the ﬁrst study [24], only individuals with severe OSA were
included and the second study included a limited number of
patients [25].
The difference in results might also be due to differences in
the tool used and cut-off points taken and this is clear in the
current study. When HDRS was used as the tool to assess
depression severity the improvement after CPAP use was very
obvious but, when SCID was used, improvement was less
obvious.
The BDI includes questions on symptoms that overlap typ-
ical OSA characteristics, such as sleepiness and fatigue, loss of
libido, and impaired concentration. This overlap does not alter
the depressive symptoms themselves but confounds interpreta-
tion of the source of the mood disturbances; we cannot disen-
tangle the extent to which individuals with depressed mood
experience a disorder independent of OSA. The DSM-IV crite-
ria for organic rule-out of a primary mood disorder, i.e., diag-
nosis of a mood disorder that is secondary to a physical
medical illness [26] do not clarify whether depressed mood in
OSA should be considered secondary to the physical disorder
[27].
Limitations of the current study include larger number of
subjects than 30 would need to be studied to verify that the
ﬁndings generalize to a larger population. Additional limita-
tions relate to the lack of objective measures of symptoms.
Also this study showed that depression is associated with
severe and moderate OSA as all patients with severe OSA
had depressive symptoms and some had moderate OSA and
this is coinciding with Carmen and Ruth [28], Also philips
et al. did not ﬁnd any signiﬁcant depressive symptoms in el-
derly patients with mild OSA as this study [11].Conclusion
OSA is associated with depressive symptoms especially severe
and moderate OSA and these symptoms improve in most cases
with CPAP treatment.
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